Medicinal – Page 21

Efficacy of extracorporeal shock wave therapy and nutraceutical supplementation in the treatment of lateral epicondylitis: a randomized controlled trial

mycolabadmin

This study tested three different treatment approaches for tennis elbow (pain in the outer elbow), a common condition affecting the forearm muscles. The treatments included shock wave therapy, a dietary supplement containing collagen and hyaluronic acid, and therapeutic exercises. The results showed that combining all three treatments was most effective, providing the best pain relief, functional improvement, and grip strength recovery within 30 days. The findings suggest that combining different treatment approaches may work better together than using them separately.

Psychedelic-induced mystical experiences: An interdisciplinary discussion and critique

mycolabadmin

This paper examines how psychedelic research studies ‘mystical experiences’—profound spiritual-type states often linked to therapeutic benefits. The authors argue that current scientific measures of these experiences are based on Western Christian and colonial-era ideas about mysticism that aren’t universal. They propose that scientists should work more closely with religious scholars and anthropologists to better understand these complex experiences across different cultures and contexts.

Psychedelics and Suicide-Related Outcomes: A Systematic Review

mycolabadmin

This comprehensive review examined how psychedelic substances like psilocybin and MDMA affect suicidal thoughts. Overall, psilocybin and MDMA-assisted therapy showed promise in reducing suicidal ideation in controlled clinical settings, with effects appearing within weeks. However, LSD use was associated with increased suicidal thoughts. The researchers conclude that while psychedelics show potential, more research is needed to ensure safety and understand how they work.

Addressing blinding in classic psychedelic studies with innovative active placebos

mycolabadmin

This research paper discusses how scientists can better test whether psychedelic drugs actually work by improving the way they conduct clinical trials. A major problem is that psychedelic drugs produce obvious effects that make it easy for patients and researchers to figure out who received the real drug versus a fake one. The authors recommend using different types of drugs as placebos that produce similar effects without being therapeutic themselves, such as certain existing medications. By using these better-designed placebos along with other strategies, future research can more definitively prove whether psychedelics truly help treat depression, chronic pain, and other conditions.

Behavioral Phenotyping and Metabolomic Comparison of Chemically Synthesized Psilocybin and Psychedelic Mushroom Extract in a Zebrafish Depression Model

mycolabadmin

Researchers compared chemically made psilocybin with whole mushroom extract in zebrafish to test for depression-like effects. Both treatments reversed depressive behaviors and produced similar changes in brain chemicals, though the mushroom extract showed more neurotransmitter precursors. This study demonstrates that zebrafish can be useful models for studying how psychedelics might help treat depression.

Factors governing consumers buying behavior concerning nutraceutical product

mycolabadmin

This study examines why people buy nutraceutical products like health supplements and functional foods. Key factors include knowing the health benefits, product taste and packaging, affordability and availability, and recommendations from healthcare professionals. The study found that age, education, and gender affect purchasing decisions, and online shopping has become increasingly important. Companies should focus on innovative products with simple health messages to better serve different consumer groups.

Biological studies of clavine alkaloids targeting CNS receptors

mycolabadmin

This paper reviews clavine alkaloids, a class of natural compounds from ergot fungi that show promise as psychiatric medications. Unlike well-known psychedelics like LSD, clavine alkaloids may provide therapeutic benefits for anxiety and depression without strong hallucinogenic effects. The authors highlight how these compounds interact with brain receptors in ways that could make them safer and more effective medications for treating mood and neurological disorders.

The release patterns and potential prebiotic characteristics of soluble and insoluble dietary fiber-bound polyphenols from pinot noir grape pomace in vitro digestion and fermentation

mycolabadmin

This study examined how grape pomace dietary fiber and its bound polyphenols are broken down in the digestive system and colon. Researchers found that soluble fiber was particularly effective at releasing beneficial compounds that feed healthy gut bacteria and produce short-chain fatty acids important for health. The fiber types promoted beneficial bacteria like Bifidobacterium while reducing harmful bacteria, suggesting grape pomace could be a valuable ingredient in functional foods to support digestive and overall health.

Prospective Comparative Study of an Oral Synbiotic and a Myoinositol-Based Herbal Supplement in Modifying Hormone Levels and the Gut Microbiome in Non-cystic Acne

mycolabadmin

This study tested two supplements for treating non-cystic acne: one containing probiotics and herbs, and another based on myoinositol and medicinal plants. Both supplements significantly reduced acne lesions and improved gut health by increasing beneficial bacteria and beneficial fatty acids produced by these bacteria. The myoinositol-based supplement also reduced hormone precursors related to acne development. These findings suggest that supporting gut health may be an effective way to treat acne.

Galacto-Oligosaccharides Exert Bifidogenic Effects at Capsule-Compatible Ultra-Low Doses

mycolabadmin

This study tested whether tiny doses of a prebiotic called galacto-oligosaccharides (GOS) could be effective when taken in capsule form instead of large sachets. Researchers used a specially designed laboratory system to simulate how these compounds work in the human gut. Even at the lowest dose tested (0.5 g), the GOS successfully increased beneficial gut bacteria and produced helpful compounds that support digestive health, while producing minimal gas.

Research Topic: Medicinal